Tuesday February 4, 2020 0 comments
ENGLEWOOD -- Zynex, Inc. (OTCQB: ZYXI), today announced it has obtained a European patent for its Blood Volume Monitor Device.
Thomas Sandgaard, the device inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.
"I am excited to have obtained European patent protection for the core principles of how we detect fluid imbalances such as excessive blood loss during surgery or internal bleeding in recovery,” said Sandgaard.
“We received a U.S. Utility Patent protection on the device about a year ago and believe this will strengthen our competitive position in the market for better fluid management in hospitals and surgical centers.
“This breakthrough technology is unique as there are no other non-invasive devices available that can detect blood loss or internal bleeding.
“We believe our non-invasive, easy-to-operate technology will serve an unmet need to manage blood volume in hospital and surgical settings, whether it is fluid loss, fluid overload or internal bleeding which is rarely detected until it becomes critical or fatal.
“It should be noted, we are still awaiting FDA clearance and European CE marking to fully launch the product into the market.
“We believe lives can be saved with this technology as significant complications are avoided during surgery. Fluid management issues can cause organs to malfunction and make recovery more difficult.”